Thursday, Dec 09, 2021 | Last Update : 07:11 PM IST

glenmark pharmaceuticals ltd

FabiFlu more economical, effective treatment option for COVID-19: Glenmark tells DGCI

Glenmark also denied making any claims that “favipiravir alone” is effective in treatment of mild-to-moderate COVID-19 patients

21 Jul 2020 3:38 PM

India's Glenmark to conduct trials for potential Covid19 drug

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%

30 Apr 2020 12:28 PM

ADVERTISEMENT
ADVERTISEMENT